|
MGAT4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.2863937106149E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.99058605341452E-13 |
| Normal-vs-Stage2 |
2.9481999952452E-08 |
| Normal-vs-Stage3 |
1.26565424807268E-14 |
| Normal-vs-Stage4 |
3.69540000044744E-07 |
| Stage1-vs-Stage2 |
9.441600E-01 |
| Stage1-vs-Stage3 |
1.073770E-02 |
| Stage1-vs-Stage4 |
6.845000E-01 |
| Stage2-vs-Stage3 |
7.139700E-02 |
| Stage2-vs-Stage4 |
6.866000E-01 |
| Stage3-vs-Stage4 |
2.925000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.42899059041702E-13 |
| Normal-vs-AfricanAmerican |
6.02695671148012E-12 |
| Normal-vs-Asian |
3.5088000000072E-05 |
| Caucasian-vs-AfricanAmerican |
7.452800E-01 |
| Caucasian-vs-Asian |
5.956400E-01 |
| AfricanAmerican-vs-Asian |
5.912400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07400763230225E-12 |
| Normal-vs-Female |
1.04329989092378E-10 |
| Male-vs-Female |
7.345000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.2406964344791E-11 |
| Normal-vs-Extreme_Weight |
1.63280500231622E-11 |
| Normal-vs-Obese |
6.75789979531771E-10 |
| Normal-vs-Extreme_Obese |
7.96980037520711E-10 |
| Normal_Weight-vs-Extreme_Weight |
4.115400E-01 |
| Normal_Weight-vs-Obese |
1.462810E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.309600E-01 |
| Extreme_Weight-vs-Obese |
5.679400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.601700E-02 |
| Obese-vs-Extreme_Obese |
6.082200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.58639999989919E-07 |
| Normal-vs-Age(41-60Yrs) |
4.51199966278182E-10 |
| Normal-vs-Age(61-80Yrs) |
6.66133814775094E-15 |
| Normal-vs-Age(81-100Yrs) |
8.185500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.039600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.649620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.968400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.098200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.037400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.301600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.02699959647623E-10 |
| Normal-VS-Type2 PRCC |
2.44249065417534E-15 |
| Normal-VS-KIRP CIMP |
1.80763999999556E-05 |
| Normal-VS-Unclassified PRCC |
2.11719999998472E-06 |
| Type1 PRCC-VS-Type2 PRCC |
2.26129999999491E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.381200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.367800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.017900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.045830E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.136800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.42028619368284E-14 |
| Normal-vs-N1 |
3.18870041482455E-10 |
| Normal-vs-N2 |
2.205700E-04 |
| N0-vs-N1 |
6.211600E-01 |
| N0-vs-N2 |
9.261800E-01 |
| N1-vs-N2 |
8.879200E-01 |
|
|
